Financials in USD. Standardized financial statements.
A compact view of how Medgroup Inc. turns revenue into operating income and net income.
| Metric | FY 1993 | FY 1992 | FY 1991 | FY 1990 | FY 1989 |
|---|---|---|---|---|---|
| Revenue? | $3.60M | $4.80M | $7.10M | $7.40M | $6.30M |
| Revenue Growth? | -25.0% | -32.4% | -4.1% | +17.5% | 0.0% |
| Cost of Revenue? | $0 | $2.60M | $3.40M | $4.20M | $2.90M |
| Gross Profit? | $3.60M | $2.20M | $3.70M | $3.20M | $3.40M |
| Gross Margin? | +100.0% | +45.8% | +52.1% | +43.2% | +54.0% |
| Operating Expenses? | $0 | $4.60M | $4.10M | $4.40M | $2.90M |
| Operating Income? | $0 | -$2.40M | -$400,000 | -$1.20M | $500,000 |
| EBITDA? | $3.60M | -$2.20M | -$200,000 | -$1.10M | $600,000 |
| Income Before Tax | $0 | $0 | $0 | -$1.10M | $400,000 |
| Income Tax Expense | $0 | $0 | $0 | -$200,000 | $100,000 |
| Net Income? | -$2.30M | -$2.00M | -$400,000 | -$900,000 | $300,000 |
| EPS? | $-0.32 | $-1.29 | $-0.25 | $-0.60 | $0.24 |
| Diluted EPS? | $-0.32 | $-1.29 | $-0.25 | $-0.60 | $0.24 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality